Top compounds associated with response to GSTCD


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA Zebularine CTRPv2 pan-cancer AAC 0.067 0.05
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.073 0.05
mRNA SU11274 CTRPv2 pan-cancer AAC 0.068 0.05
mRNA Vandetanib CCLE pan-cancer AAC 0.093 0.05
mRNA semagacestat CTRPv2 pan-cancer AAC -0.071 0.05
mRNA RDEA119 FIMM pan-cancer AAC -0.35 0.06
mRNA pluripotin CTRPv2 pan-cancer AAC -0.067 0.06
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.065 0.06
Download CSV